This inventor holds 12 USPTO granted patents, plus 1 CIPO patent and 6 EPO patents. Top assignee: University of Pittsburgh. Active years: 2015-2020.
Location History:
- Port St. Lucie, FL (US) (2015 - 2017)
- North Huntingdon, PA (US) (2017 - 2020)
Company Filing History:
Years Active: 2015-2020
Title: Innovations by Corey J Crevar
Introduction
Corey J Crevar is an accomplished inventor based in North Huntingdon, PA (US). With a total of 12 patents to his name, he has made significant contributions to the field of immunology, particularly in the development of antigens for influenza viruses.
Latest Patents
Among his latest patents are two notable innovations focused on optimizing antigens for influenza viruses. The first patent, titled "Computationally optimized broadly reactive antigens for human and avian H5N1 influenza," describes the generation of optimized H5N1 influenza HA polypeptides. These polypeptides are designed to elicit a broadly reactive immune response to various H5N1 influenza virus isolates. The development process involved a series of HA protein alignments and the generation of consensus sequences based on human and avian H5N1 isolates. The patent also includes optimized H5N1 HA polypeptides, compositions, fusion proteins, and VLPs comprising these polypeptides, along with codon-optimized nucleic acid sequences encoding them.
The second patent, "Computationally optimized broadly reactive antigens for H1N1 influenza," follows a similar approach. It focuses on the generation of optimized H1N1 influenza HA polypeptides aimed at eliciting a broadly reactive immune response to H1N1 influenza virus isolates. This innovation also involved HA protein alignments and consensus sequence generation based on selected H1N1 viruses isolated from 1918 to 2011. The patent provides optimized H1N1 HA polypeptides, compositions, fusion proteins, and VLPs, as well as codon-optimized nucleic acid sequences encoding these polypeptides.
Career Highlights
Corey J Crevar is affiliated with the University of Pittsburgh, where he continues to advance research in the field of immunology. His work has been instrumental in developing new strategies for combating influenza viruses, which pose significant public health challenges.
Collaborations
Corey collaborates with notable colleagues, including Ted M Ross and Donald Martin Carter, Jr. Their combined expertise enhances the research efforts in developing effective vaccines and treatments for influenza.
Conclusion
Corey J Crevar's innovative work in optimizing antigens for influenza viruses showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight